Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00401232 · ClinicalTrials.gov registry record · NA
Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development
A NA study, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
- 955
- Enrollment target
NCT00401232 is a NA study that has completed, run by Pfizer. The registered enrollment target is 955 participants.
The verdict
NCT00401232, a NA study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
- 955 participants
- Enrollment target
Study Summary
This is a study to collect blood from volunteers to assist in assay development.
Interventions
- PROCEDURE Blood Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 955 participants |
| Start Date | 2006-08 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00401232
The ClinicalTrials.gov registry entry for NCT00401232 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 955 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood Collection is the first listed.
NCT00401232 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00401232 about?
NCT00401232 is a clinical study titled "Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development". This is a study to collect blood from volunteers to assist in assay development.
What is the current status of trial NCT00401232?
This trial is currently completed. It is a NA study. The enrollment target is 955 participants. The study started on 2006-08. Estimated completion is 2017-12.
What interventions are being tested in trial NCT00401232?
The interventions under investigation include: Blood Collection (PROCEDURE).
Who is sponsoring clinical trial NCT00401232?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.